why choose us

First received: November 04, 2024

Clinical Trial: A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Compensated Liver Cirrhosis

Study Type: INTERVENTIONAL


Official Title: Safety, Tolerability and Pharmacodynamics of BI 770371 Administered Intravenously in Patients With Compensated Cirrhosis Due to MASH: a Phase IIa, Multi-center, Randomized, Double-blind, Placebo-contr

Brief Summary: This study is open to people with cirrhosis caused by a liver disease called MASH (metabolic dysfunction-associated steatohepatitis).The purpose of this study is to find out how well a medicine called BI 770371 is tolerated.Participants are put into 2 groups by chance.One group gets BI 770371 as an infusion into a vein and the other group gets placebo as an infusion into a vein.Placebo infusions look like BI 770371 infusions but do not contain any medicine.Participants get an infusion every 3 weeks for 12…

Read more